A study investigating the efficacy of our FDA-clea
Post# of 7798
(Total Views: 222)
Posted On: 03/22/2024 10:16:48 PM
A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info@bielcorp.com or 866-757-2284 to request sample products.
https://lnkd.in/eq5hyD3c
#caninearthritismanagement #osteoarthritis #osteoarthritistreatment #veterinarymedicine #veterinarycare #seniordogs #caninearthritis
Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
onlinelibrary.wiley.com
https://www.linkedin.com/feed/update/activity...9792514050
https://lnkd.in/eq5hyD3c
#caninearthritismanagement #osteoarthritis #osteoarthritistreatment #veterinarymedicine #veterinarycare #seniordogs #caninearthritis
Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
onlinelibrary.wiley.com
https://www.linkedin.com/feed/update/activity...9792514050
(0)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼